Table 1.

Non-oncological patients affected by BRONJ on oral bisphosphonates: clinical features and medication history

Patient	Gender	Age	Mandible, maxilla, both	Exposed bone, ≥ 8 weeks	Stage	Pain at ONJ site	Dental extraction/ dental implants	Surgery	Bisphosphonate type	Duration BP use (mos)	Improved
1	M	69	Mandible	Yes	3	Yes	Yes	Yes	Alendronate, bandronate	60	Yes
2	F	62	Mandible	Yes	1	No	No	Yes	Alendronate, Ibandronate	60	Yes
3	F	57	Maxilla	Yes	1	Yes	No	Yes	Alendronate	66	Yes
4	F	74	Maxilla	Yes	1	No	Yes	No	Alendronate	72	No
5	F	71	Maxilla	Yes	2	Yes	Yes	Yes	Alendronate	>24	Yes
6	F	69	Mandible	Yes	3	Yes	Yes	Yes	Alendronate	42	Yes
7	F	55	Mandible	Yes	1	Yes	Yes	No	Alendronate	18	No
8	F	61	Both	Yes	2/3	Yes	Yes	Yes	Alendronate	…	Yes
9	F	64	Mandible	Yes	2	Yes	Yes	No	Alendronate	120	Yes
10	M	62	Maxilla	Yes	2	Yes	Yes	No	Alendronate	24	Yes
11	F	85	Mandible	Yes	2	No	No	No	Alendronate	6	Yes
12	F	62	Maxilla	Yes	2	Yes	Yes	No	Alendronate	24	Yes
13	F	76	Both	Yes	1	Yes	Yes	No	Alendronate	120	Yes
14	F	90	Maxilla	Yes	1	No	No	Yes	Alendronate	84	…
15	F	57	Maxilla	Yes	1	Yes	Yes	Yes	Alendronate	24	Yes
16	F	84	Mandible	Yes	2	Yes	No	No	Alendronate	96	No
17	F	51	Mandible	Yes	2	Yes	No	Yes	Ibandronate	33	Yes
18	F	64	Mandible	Yes	2	Yes	Yes	No	Pamidronate	2	No

The ellipse (…) denotes missing data from the record review.